Mucoepidermoid carcinoma of the larynx is an uncommon malignancy. Nearly all cases are found in middle-aged and elderly men. Most cases arise in the supraglottis. Mucoepidermoid carcinoma is classified histologically as low grade and high grade. The prognosis is relatively good for low-grade tumor and poor for high-grade mucoepidermoid carcinoma, which is also referred to as adenosquamous carcinoma. The treatment is primarily surgical, although the efficacy of post-operative radiation, with and without chemotherapy, is presently under evaluation in a National Intergroup Study. The case reported here is nearly classic for high-grade mucoepidermoid carcinoma, both as to clinical presentation and morphology. This report and discussion are offered to familiarize the reader with this uncommon lesion, of which fewer than 80 cases have been reported.
Download full-text PDF |
Source |
---|
Ear Nose Throat J
January 2025
Ear, Nose, and Throat Department, General Hospital of Athens "G. Gennimatas," Athens, Greece.
Genes (Basel)
December 2024
School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Salivary gland carcinomas encompass a broad group of malignant lesions characterized by varied prognoses. Stem cells have been associated with the potential for self-renewal and differentiation to various subpopulations, resulting in histopathological variability and diverse biological behavior, features that characterize salivary gland carcinomas. This study aims to provide a thorough systematic review of immunohistochemical studies regarding the expression and prognostic significance of stem cell markers between different malignant salivary gland tumors (MSGTs).
View Article and Find Full Text PDFBMJ Case Rep
January 2025
Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Salivary gland malignancies are rare, accounting for less than 5% of head and neck cancers. Mucoepidermoid carcinoma (MEC) is the most common salivary gland tumour, predominantly found in the parotid gland. However, it has rarely been reported in the tongue.
View Article and Find Full Text PDFAppl Radiat Isot
January 2025
Department of Otolaryngology Head and Neck Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Japan; BNCT Joint Clinical Institute, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Purpose: Boron neutron capture therapy (BNCT) perform as a treatment option for locally advanced or recurrent unresectable head and neck cancers since June 2020 in Japan. The effect of BNCT on parotid carcinoma, which presents a variety of histologic types, remains unclear. The object of this study was to investigate the antitumor efficacy of BNCT against parotid gland carcinoma by focusing on LAT1, which is involved in the uptake of L-BPA, the boron compound used in BNCT.
View Article and Find Full Text PDFSLAS Discov
January 2025
Center of Excellence and Innovation for Oral Health and Healthy Longevity, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!